MaagLeverDarm Stichting   Report issue

Academic/Hospital Phase 4
Founded: Netherlands

Organization Overview

First Clinical Trial
2013
NCT01740947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

amphotericin b (fungizone) (1 trial)

colistin (1 trial)

tobramycin (nebcin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3